• Skip to primary navigation
  • Skip to main content

Yamo Pharmaceuticals

Cutting Edge Pharmaceutial Technologies

  • Technology
    • Yamo’s Treatment for Autism
    • About Autism
  • Information for Patients and Caregivers
    • Future Clinical Studies
    • Compassionate Use Policy
  • Company
    • Overview
    • Our Team
    • Scientific Advisory Board
  • News & Publications
  • Contact Us
    • General Inquiries
    • Participation in Future Clinical Studies

News & Events · April 17, 2018

Safety of L1-79 in Autism

https://clinicaltrials.gov/ct2/show/NCT02947048

Filed Under: News & Events

admin

  • Copyright © 2023 Yamo Pharmaceuticals
  • Terms and Conditions
  • Privacy Policy